Clinical Trials
Clinical Trials at Willis Knighton Health elevate medical science and treatments
Are you ready to take a more active role in your health? Would you like to have early access to new treatments and therapies before they become widely available? Whether you are healthy today or have a medical diagnosis you want to address, volunteering for clinical trials elevates medical expertise and treatments.
A strong commitment to our community’s health and well-being inspires Willis Knighton to advance treatment for diseases that affect people in our region.
Our approach to clinical trials
Your health is our priority. As we review options for clinical trials, we identify those that will allow us to participate in research that will advance healthcare in our community and our world.
Why choose us for clinical trials?
You have access to a wide range of clinical trials through Willis Knighton Health and Physician Network doctors. Our team will help ensure that your treatment plan is safe and effective for your long-term health management goals. You may qualify for trials that address:
- Screening
- Diagnostics
- Treatments
- Different kinds of therapy
- Prevention
- Quality of life
Phases of Clinical Trials
Clinical trials are conducted in phases that build on each other as information is learned about the drug, device or treatment being studied. Each phase has its own benefits and risks.
Phase 0 – Designed to be small for a short period of time. The purpose is to see if the drug or treatment does what it’s expected to do. For example, evidence that the drug reaches the targeted tumor for treatment.
Phase I - Test a new therapy for the first time in a small group of people. Determine if it is safe, find the right dose, and learn about side effects.
Phase II - Involve more people to see how the new therapy treats a disease and whether the treatment is safe.
Phase III - Expand study to include larger groups of people to see how the new therapy works, if it has side effects, and how it compares to other therapies.
Phase IV - Review the effects of new drugs and treatments over time in large groups of people after treatment is approved by the U.S. Food and Drug Administration (FDA). They may focus on specific ages, genders, races, people taking other medications, or people who have other diseases.




